SIGALA, Sandra
 Distribuzione geografica
Continente #
NA - Nord America 9.858
AS - Asia 4.853
EU - Europa 4.413
SA - Sud America 855
AF - Africa 81
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.079
Nazione #
US - Stati Uniti d'America 9.727
SG - Singapore 1.678
CN - Cina 1.620
UA - Ucraina 893
BR - Brasile 721
IT - Italia 694
HK - Hong Kong 623
DE - Germania 609
PL - Polonia 574
FI - Finlandia 386
FR - Francia 309
VN - Vietnam 301
GB - Regno Unito 253
RU - Federazione Russa 209
TR - Turchia 181
IE - Irlanda 161
IN - India 155
SE - Svezia 88
CA - Canada 75
BD - Bangladesh 57
BE - Belgio 54
JP - Giappone 50
AR - Argentina 48
ID - Indonesia 46
NL - Olanda 40
CZ - Repubblica Ceca 34
ZA - Sudafrica 33
MX - Messico 32
EC - Ecuador 26
IQ - Iraq 25
ES - Italia 23
PK - Pakistan 20
AT - Austria 16
AU - Australia 13
CL - Cile 13
IR - Iran 11
UZ - Uzbekistan 11
VE - Venezuela 11
KE - Kenya 10
LT - Lituania 10
MA - Marocco 10
PY - Paraguay 10
CO - Colombia 9
DK - Danimarca 9
EE - Estonia 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 7
EG - Egitto 7
CH - Svizzera 6
JM - Giamaica 6
MU - Mauritius 6
BG - Bulgaria 5
BO - Bolivia 5
DZ - Algeria 5
JO - Giordania 5
LB - Libano 5
PT - Portogallo 5
UY - Uruguay 5
AZ - Azerbaigian 4
EU - Europa 4
GR - Grecia 4
IL - Israele 4
KG - Kirghizistan 4
OM - Oman 4
PE - Perù 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
CR - Costa Rica 3
GY - Guiana 3
KR - Corea 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GD - Grenada 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
MY - Malesia 2
PH - Filippine 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
ZW - Zimbabwe 2
AM - Armenia 1
AO - Angola 1
BY - Bielorussia 1
BZ - Belize 1
ET - Etiopia 1
GT - Guatemala 1
KH - Cambogia 1
Totale 20.068
Città #
Fairfield 1.045
Woodbridge 835
Ashburn 813
Singapore 738
Jacksonville 652
Hong Kong 618
Warsaw 570
Houston 526
Seattle 426
Cambridge 421
Ann Arbor 376
Dallas 375
Wilmington 356
Beijing 348
Chandler 339
Princeton 291
Los Angeles 257
Chicago 240
Nanjing 227
New York 211
Helsinki 206
Brescia 199
Dearborn 169
Dublin 160
Istanbul 147
Des Moines 108
Munich 108
Nanchang 108
Salt Lake City 100
Buffalo 94
Ho Chi Minh City 89
Moscow 86
Shenyang 69
Secaucus 67
Turku 64
Shanghai 62
Changsha 60
São Paulo 60
The Dalles 60
Jinan 57
Hanoi 56
Redondo Beach 55
San Diego 55
Brussels 53
Tampa 52
Tianjin 50
Elk Grove Village 49
Santa Clara 49
Dong Ket 48
Hebei 48
Milan 47
San Francisco 45
Pune 44
West Jordan 44
Lancaster 41
Toronto 39
London 36
Kunming 32
Boardman 31
Jakarta 31
Jiaxing 31
Sterling 31
Tokyo 29
Brooklyn 28
Ningbo 27
Rio de Janeiro 25
Brno 23
Rome 23
Zhengzhou 23
Verona 22
Taizhou 21
Johannesburg 19
Nuremberg 19
Boston 18
Dalmine 18
Hangzhou 18
Phoenix 18
Guangzhou 17
Haikou 17
Düsseldorf 15
Norwalk 15
Poplar 15
Romola 15
Stockholm 15
Atlanta 14
Haiphong 14
Miami 14
Denver 13
Dulles 13
Kyiv 13
Montreal 13
Belo Horizonte 12
Brasília 12
Ashiya 11
Chennai 11
Frankfurt am Main 11
Kocaeli 11
Lanzhou 11
Olomouc 11
Tashkent 11
Totale 13.339
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 762
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 359
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 358
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 279
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 276
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 253
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 224
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 223
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 223
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 204
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 201
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 196
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 195
Immunotherapy failure in adrenocortical cancer: where next? 194
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 192
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 190
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 190
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 184
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 183
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 181
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 177
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 177
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 176
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 176
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 175
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 173
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 171
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 169
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 169
Palbociclib inhibits proliferation of human adrenocortical tumor cells 168
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 164
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 160
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 160
A new pharmacological approach to the facilitation of acetylcholine transmission. 159
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 158
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 155
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 154
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 150
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 148
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 146
INVOLVEMENT OF TARGET GENE POLYMORPHISMS IN 5-FLUOROURACIL TOXICITY: A CASE REPORT 145
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 144
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 142
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? 139
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 139
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines 139
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 137
Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs 135
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 134
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. 133
Dopamine receptors are present in rat and human esophagus 132
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 131
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 130
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 128
Nerve growth factor signaling in prostate health and disease. 128
Sex-related variations in serum nerve growth factor concentration in humans. 127
Different neurotransmitter systems are involved in the development of esophageal achalasia 123
Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender-dependent modifications 123
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 121
Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. 121
Clinical Outcome After Extended Endovascular Recanalization in Buerger's Disease in 20 Consecutive Cases. 121
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 121
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 119
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 119
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice. 119
Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer 119
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 118
Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment 117
Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus 116
Adrenocortical carcinoma 116
Should we be cautious on the use of commercially available antibodies to dopamine receptors? 115
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 114
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 113
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 113
I RECETTORI ADRENERGICI ALFA-1 NELL'APPARATO URINARIO UMANO: ESPRESSIONE DISTRIBUZIONE E LORO IMPLICAZIONI CLINICHE 112
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 111
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism 111
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 111
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 111
Erratum to "Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa" [Pharmacol. Res. 64 (2011) 420-425] 111
Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment 111
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 109
Differential gene expression of dopamine D-2 receptor subtypes in rat chromaffin cells and sympathetic neurons in culture. 107
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 107
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 102
Identification of Dopamine receptors in rat and human esophagus 101
MUSCARINIC RECEPTOR MESSENGER RNAs ARE DIFFERENTIALLY EXPRESSED IN MALE AND FEMALE NORMAL HUMAN BLADDER 101
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 100
D-1 and D-2 dopamine receptors in rat lower esophageal sphincter: a functional study 100
Phenotype changes of prolactinomas 99
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 99
ALPHA 1 ADRENERGIC RECEPTOR SUBTYPES IN MALE AND FEMALE HUMAN URINARY BLADDER: SEX AND REGIONAL COMPARISON 97
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 97
Stimulation of muscarinic receptors induces cell proliferation of human detrusor muscle cell 95
Caffeine inhibits Direct and Indirect Angiogenesis in zebrafish embryos 94
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 94
Molecular and pharmacological detection of dopaminergic receptors in the human male urinary tract 94
role of acetylcholine as a growth factor: focus on human urinary bladder 94
Ruolo della dopamina e del VIP sulla funzione motoria del LES nell'acalasia esofagea 92
D-1 and D-2 dopamine receptors in rat esophagus: biochemical and functional characterization 92
Totale 15.295
Categoria #
all - tutte 92.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.486 0 0 0 0 0 250 107 259 310 219 224 117
2021/20221.260 120 185 38 68 15 58 63 76 61 154 112 310
2022/20231.075 190 62 48 81 83 260 6 90 134 14 39 68
2023/20241.412 72 39 126 101 82 256 49 67 284 73 34 229
2024/20254.152 56 47 32 529 341 246 295 109 491 248 942 816
2025/20263.766 550 864 757 917 608 70 0 0 0 0 0 0
Totale 20.412